Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Drug makers fuming at ‘overpriced’ values placed on their myeloma drugs
Drug makers fuming at ‘overpriced’ values placed on their myeloma drugs
Drug makers fuming at ‘overpriced’ values placed on their myeloma drugs
Submitted by
admin
on May 16, 2016 - 3:55pm
Source:
Stat
News Tags:
Multiple Myeloma
Amgen
Kyprolis
Headline:
Drug makers fuming at ‘overpriced’ values placed on their myeloma drugs
Do Not Allow Advertisers to Use My Personal information
